Long-term efficacy of sensor-augmented pump therapy (Minimed 640G system) combined with a telemedicine follow-up in patients with type 1 diabetes: A real life study

•Real-life effectiveness of sensor-augmented pump therapy with predictive low-glucose management (SAP-PGLM) over a 3-years period in 62 patients with type 1 diabetes (T1D)•Interest to combine SAP-PGLM with telemedicine to achieve good and sustainable real-life therapeutic adherence in T1D patients.•Reduction of hypoglycemia and improvement in HbA1c in T1D patients with SAP-PGLM under real-life conditions.